Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

Antonio Jimenez, MD, Mohamed I. Farhat, MD, Stephanie A. Gregory, MD, Mohamad Kassar, MD, Alla Gimelfarb, MD, Marta Batus, MD, Julie Nangia, MD, Neel Shah, MD, Parameswaran Venugopal, MD, Melissa L. Larson, MD, Kent W. Christopherson, PHD, Henry C. Fung, MD

Blood (2007) 110 (11): 5044.

https://doi.org/10.1182/blood.V110.11.5044.5044

Published: 2007

Journal Articles

CD26 Inhibition on CD34 + or Lineage − Human Umbilical Cord Blood Donor HSC/HPC Improves Long-Term Engraftment into NOD/SCID/Beta2 null Immunodeficient Mice.

Kent W. Christopherson, PhD, Laura A. Paganessi, Stephanie Napier, Nehal K. Porecha

Blood (2007) 110 (11): 4853.

https://doi.org/10.1182/blood.V110.11.4853.4853

Published: 2007

Journal Articles

In Vivo Expansion of Megakaryocyte Progenitors in CD26 −/ − Mice: Implications for Novel Post-Transplant Therapeutics.

Shannon Kidd, Carlos E. Bueso-Ramos, MD, Laura A. Paganessi, Henry Fung, MD, Stephanie Gregory, MD, Kent W. Christopherson, PhD

Blood (2007) 110 (11): 1188.

https://doi.org/10.1182/blood.V110.11.1188.1188

Published: 2007

Journal Articles

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Kent W. Christopherson, PhD, Laura A. Paganessi, MA, Darilyn R. Rhoades, RN, Hortense M. Dillon, CMA, Sefer Gezer, MD, Melissa L. Larson, MD, Henry C. Fung, MD, Stephanie A. Gregory, MD

Blood (2007) 110 (11): 4711.

https://doi.org/10.1182/blood.V110.11.4711.4711

Published: 2007

Journal Articles

Mesenchymal Stem Cells from the Wharton’s Jelly of Umbilical Cord Segments Support the Maintenance of Long Term Culture-Initiating Cells from Cord Blood.

Kent W. Christopherson, PhD, Tiki Bakhshi, M.D., Shamanique Bodie, M.D., Shannon Kidd, Ryan Zabriskie, Susan Ramin, M.D.

Blood (2006) 108 (11): 3650.

https://doi.org/10.1182/blood.V108.11.3650.3650

Published: 2006

Journal Articles

Cytokine Induced Changes in the Hematopoietic Stem Cell Trafficking Regulatory Peptidase CD26.

Kent W. Christopherson, PhD, Sherene E. Uralil, Shannon M. Kidd, Nehal K. Porecha, Ryan C. Zabriskie

Blood (2005) 106 (11): 5220.

https://doi.org/10.1182/blood.V106.11.5220.5220

Published: 2005

NARROW

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

CD26 Inhibition on CD34 + or Lineage − Human Umbilical Cord Blood Donor HSC/HPC Improves Long-Term Engraftment into NOD/SCID/Beta2 null Immunodeficient Mice.

In Vivo Expansion of Megakaryocyte Progenitors in CD26 −/ − Mice: Implications for Novel Post-Transplant Therapeutics.

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Mesenchymal Stem Cells from the Wharton’s Jelly of Umbilical Cord Segments Support the Maintenance of Long Term Culture-Initiating Cells from Cord Blood.

Cytokine Induced Changes in the Hematopoietic Stem Cell Trafficking Regulatory Peptidase CD26.

Email alerts

ASH Publications

American Society of Hematology

Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study.

CD26 Inhibition on CD34 + or Lineage − Human Umbilical Cord Blood Donor HSC/HPC Improves Long-Term Engraftment into NOD/SCID/Beta2 null Immunodeficient Mice.

In Vivo Expansion of Megakaryocyte Progenitors in CD26 −/ − Mice: Implications for Novel Post-Transplant Therapeutics.

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Mesenchymal Stem Cells from the Wharton’s Jelly of Umbilical Cord Segments Support the Maintenance of Long Term Culture-Initiating Cells from Cord Blood.

Cytokine Induced Changes in the Hematopoietic Stem Cell Trafficking Regulatory Peptidase CD26.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only